Next Article in Journal
Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
Next Article in Special Issue
Potential Factors Influencing the Effects of Anthocyanins on Blood Pressure Regulation in Humans: A Review
Previous Article in Journal
Dietary Protein and Amino Acid Intake: Links to the Maintenance of Cognitive Health
Previous Article in Special Issue
Blackcurrant (Ribes nigrum) Extract Exerts an Anti-Inflammatory Action by Modulating Macrophage Phenotypes
Open AccessArticle

Aronia Berry Supplementation Mitigates Inflammation in T Cell Transfer-Induced Colitis by Decreasing Oxidative Stress

1
Department of Food Science, University ofWisconsin-Madison, 1605 Linden Dr., Madison, WI 53706, USA
2
China Agricultural University, College of Food Science and Nutritional Engineering, No.17 Qinghua Dong Lu, Beijing 100083, China
3
Wisconsin Institutes for Medical Research, University ofWisconsin-Madison, 1111 Highland Ave., Madison, WI 53706, USA
4
Mass Spectrometry Facility, Biotechnology Center, University ofWisconsin-Madison, 425 Henry Mall, Madison, WI 53706, USA
5
University of Massachusetts, Amherst, School of Public Health and Health Sciences, 100 HoldsworthWay, Amherst, MA 01003, USA
*
Authors to whom correspondence should be addressed.
Nutrients 2019, 11(6), 1316; https://doi.org/10.3390/nu11061316
Received: 9 May 2019 / Revised: 7 June 2019 / Accepted: 10 June 2019 / Published: 12 June 2019
(This article belongs to the Special Issue Dietary Anthocyanins and Human Health)
Oxidative stress is involved in the pathogenesis and progression of inflammatory bowel disease. Consumption of aronia berry inhibits T cell transfer colitis, but the antioxidant mechanisms pertinent to immune function are unclear. We hypothesized that aronia berry consumption could inhibit inflammation by modulating the antioxidant function of immunocytes and gastrointestinal tissues. Colitis was induced in recombinase activating gene-1 deficient (Rag1-/-) mice injected with syngeneic CD4+CD62L+ naïve T cells. Concurrent with transfer, mice consumed either 4.5% w/w aronia berry-supplemented or a control diet for five weeks. Aronia berry inhibited intestinal inflammation evidenced by lower colon weight/length ratios, 2-deoxy-2-[18F]fluoro-d-glucose (FDG) uptake, mRNA expressions of tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) in the colon. Aronia berry also suppressed systemic inflammation evidenced by lower FDG uptake in the spleen, liver, and lung. Colitis induced increased colon malondialdehyde (MDA), decreased colon glutathione peroxidase (GPx) activity, reduced glutathione (rGSH) level, and suppressed expression of antioxidant enzymes in the colon and mesenteric lymph node (MLN). Aronia berry upregulated expression of antioxidant enzymes, prevented colitis-associated depletion of rGSH, and maintained GPx activity. Moreover, aronia berry modulated mitochondria-specific antioxidant activity and decreased splenic mitochondrial H2O2 production in colitic mice. Thus, aronia berry consumption inhibits oxidative stress in the colon during T cell transfer colitis because of its multifaceted antioxidant function in both the cytosol and mitochondria of immunocytes. View Full-Text
Keywords: aronia berry; adoptive transfer colitis; inflammatory bowel disease; oxidative stress aronia berry; adoptive transfer colitis; inflammatory bowel disease; oxidative stress
Show Figures

Graphical abstract

MDPI and ACS Style

Pei, R.; Liu, J.; Martin, D.A.; Valdez, J.C.; Jeffety, J.; Barrett-Wilt, G.A.; Liu, Z.; Bolling, B.W. Aronia Berry Supplementation Mitigates Inflammation in T Cell Transfer-Induced Colitis by Decreasing Oxidative Stress. Nutrients 2019, 11, 1316.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop